Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

11,836 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Bioequivalence of a hybrid pegylated liposomal doxorubicin hydrochloride injection and Caelyx®: A single-dose, randomized, multicenter, open-label, two-period crossover study in patients with advanced ovarian cancer.
Prakash SS, Nagarkar RV, Puligundla KC, Lokesh KN, Boya RR, Patel AB, Goyal L, Thoke A, Patel JG, Mehta AO, Patel GN, Khan MA, Ahmad I. Prakash SS, et al. Among authors: patel ab. Eur J Pharm Sci. 2022 Jun 28:106248. doi: 10.1016/j.ejps.2022.106248. Online ahead of print. Eur J Pharm Sci. 2022. PMID: 35777616
11,836 results
You have reached the last available page of results. Please see the User Guide for more information.